Latest & greatest articles for covid-19

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on covid-19 or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on covid-19 and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for covid-19

21. Evaluation of the Current Therapeutic Approaches for COVID-19: A Systematic Review and a Meta-analysis Full Text available with Trip Pro

-Haddad M., Al-Muhaini A., Al-Ghimlas F., et al. (2020). Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait. EClinicalMedicine 24, 100448. 10.1016/j.eclinm.2020.100448 - - - Asai N., Sakanashi D., Nakamura A., Kishino T., Kato H., Hagihara M., et al. (2020). Clinical manifestations and radiological features by chest computed tomographic findings of a novel coronavirus disease-19 pneumonia among 92 patients in Japan. J. Microbiol (...) Evaluation of the Current Therapeutic Approaches for COVID-19: A Systematic Review and a Meta-analysis Evaluation of the Current Therapeutic Approaches for COVID-19: A Systematic Review and a Meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account info Close Account Logged in as: username

2021 EvidenceUpdates

22. PHE monitoring of the effectiveness of COVID-19 vaccination

PHE monitoring of the effectiveness of COVID-19 vaccination PHE monitoring of the effectiveness of COVID-19 vaccination - GOV.UK Cookies on GOV.UK We use some essential cookies to make this website work. We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services. We also use cookies set by other sites to help us deliver content from their services. Accept additional cookies Reject additional cookies You can at any time. Hide (...) this message Show or hide search Search on GOV.UK Search Menu National lockdown: stay at home Check what you need to do Guidance PHE monitoring of the effectiveness of COVID-19 vaccination Data on the real-world efficacy of the COVID-19 vaccines. From: Published: 22 February 2021 Last updated: 17 March 2021, Documents Ref: PHE publications gateway number: GOV-7777 . Please tell us what format you need. It will help us if you say what assistive technology you use. Ref: PHE publications gateway number: GW

2021 Public Health England

23. COVID-19 rapid guideline: managing COVID-19

COVID-19 rapid guideline: managing COVID-19 COVID-19 rapid guideline: managing COVID-19 NICE guideline Published: 23 March 2021 www.nice.org.uk/guidance/ng191 © NICE 2021. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement (...) . Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. COVID-19 rapid guideline: managing COVID-19 (NG191) © NICE 2021. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 10Contents Contents Overview 4 Recommendations 6 Update information 10 COVID-19 rapid guideline

2021 National Institute for Health and Clinical Excellence - Clinical Guidelines

24. COVID-19: ventilation of indoor spaces to stop the spread of coronavirus

COVID-19: ventilation of indoor spaces to stop the spread of coronavirus COVID-19: ventilation of indoor spaces to stop the spread of coronavirus - GOV.UK Cookies on GOV.UK We use some essential cookies to make this website work. We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services. We also use cookies set by other sites to help us deliver content from their services. Accept additional cookies Reject additional cookies You (...) can at any time. Hide this message Show or hide search Search on GOV.UK Search Menu National lockdown: stay at home Check what you need to do Guidance COVID-19: ventilation of indoor spaces to stop the spread of coronavirus Guidance on the ventilation of indoor spaces to stop the spread of coronavirus (COVID-19). From: Published: 4 March 2021 Applies to: England Documents HTML Details Advice and information on how ventilation of indoor spaces can help to stop the spread of coronavirus (COVID-19

2021 Public Health England

25. Considerations on the use of self-tests for COVID-19 in the EU/EEA

Considerations on the use of self-tests for COVID-19 in the EU/EEA Considerations on the use of self-tests for COVID-19 in the EU/EEA Global Navigation Other sites: European Centre for Disease Prevention and Control An agency of the European Union Main Navigation Secondary Navigation Search Search Search Search Considerations on the use of self-tests for COVID-19 in the EU/EEA Considerations on the use of self-tests for COVID-19 in the EU/EEA Technical report 17 Mar 2021 Cite: European Centre (...) for Disease Prevention and Control. Considerations on the use of self-tests for COVID-19 in the EU/EEA – 17 March 2021. ECDC: Stockholm; 2021. This document outlines the public health considerations for the use of self-tests to detect SARS-CoV-2 by public health authorities in the European Union/European Economic Area (EU/EEA). Only rapid antigen detection tests (RADTs) for self-testing for direct detection of SARS-CoV-2 virus particles in infectious individuals are considered within this document

2021 European Centre for Disease Prevention and Control - Covid-19 Guidance

26. Stress test on logistical aspects of COVID-19 vaccination deployment plans for the Western Balkans: final report

Stress test on logistical aspects of COVID-19 vaccination deployment plans for the Western Balkans: final report Stress test on logistical aspects of COVID-19 vaccination deployment plans for the Western Balkans: final report Global Navigation Other sites: European Centre for Disease Prevention and Control An agency of the European Union Main Navigation Secondary Navigation Search Search Search Search Stress test on logistical aspects of COVID-19 vaccination deployment plans for the Western (...) Balkans: final report Stress test on logistical aspects of COVID-19 vaccination deployment plans for the Western Balkans: final report Technical report 18 Mar 2021 Cite: European Centre for Disease Prevention and Control. Stress test on logistical aspects of COVID-19 vaccination deployment plans for the Western Balkans: final report. 18 March 2021. ECDC: Stockholm; 2021. ECDC, together with the European Commission’s Directorate-General for Health and Food Safety, and supported by the Commission’s

2021 European Centre for Disease Prevention and Control - Covid-19 Guidance

27. Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19: A Meta-Analysis and Systematic Review Full Text available with Trip Pro

Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19: A Meta-Analysis and Systematic Review Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19: A Meta-Analysis and Systematic Review - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account info Close Account Logged in as: username Search (...) Cite Display options Display options Format Share Permalink Copy Page navigation Cureus Actions . 2021 Feb 4;13(2):e13124. doi: 10.7759/cureus.13124. Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19: A Meta-Analysis and Systematic Review , , , , Affiliations Expand Affiliation 1 Internal Medicine, Saint Francis Medical Center, Trenton, USA. PMID: 33728141 PMCID: DOI: Free PMC article Item in Clipboard Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19: A Meta-Analysis

2021 EvidenceUpdates

28. Diagnostic Accuracy of North America Expert Consensus Statement on Reporting CT Findings in Patients Suspected of Having COVID-19 Infection: An Italian Single-Center Experience Full Text available with Trip Pro

Diagnostic Accuracy of North America Expert Consensus Statement on Reporting CT Findings in Patients Suspected of Having COVID-19 Infection: An Italian Single-Center Experience Diagnostic Accuracy of North America Expert Consensus Statement on Reporting CT Findings in Patients Suspected of Having COVID-19 Infection: An Italian Single-Center Experience - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search (...) History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account info Close Account Logged in as: username Search: Search Save Email Send to Display options Display options Format Save citation to file Format: Create file Cancel Email citation Subject: 1 selected item: 33778611 - PubMed To: Format: MeSH and other data Send email Cancel Add to Collections Create a new collection Add to an existing collection Name your collection: Name must be less than 100

2021 EvidenceUpdates

29. Accuracy and Reproducibility of Low-Dose Submillisievert Chest CT for the Diagnosis of COVID-19 Full Text available with Trip Pro

human coronaviruses. Adv Virus Res 2018;100:163–188. - - Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497–506 [Published correction appears in Lancet 2020;395(10223):496.]. - - World Health Organization . Coronavirus disease (COVID-19) outbreak. . 2020. Accessed April 15, 2020. Fang Y, Zhang H, Xie J, et al. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology 2020 Feb 19:200432 [Epub ahead (...) of print]. Pan F, Ye T, Sun P, et al. Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. Radiology 2020 Feb 13:200370 [Epub ahead of print]. Show all 19 references Related information LinkOut - more resources Full Text Sources Full text links [x] [x] Cite Copy Download .nbib Format: Send To [x] NCBI Literature Resources Follow NCBI National Library of Medicine

2021 EvidenceUpdates

30. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis Full Text available with Trip Pro

The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account info Close Account Logged in as: username Search: Search Save Email Send to Display (...) Format Share Permalink Copy Page navigation CMAJ Actions . 2021 Apr 19;193(16):E540-E548. doi: 10.1503/cmaj.202604. Epub 2021 Mar 19. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis , , , Affiliations Expand Affiliations 1 Department of Obstetrics and Gynecology (Wei), Centre hospitalier universitaire Sainte-Justine; Centre de recherche du Centre hospitalier de l'Université de Montréal, Department of Social and Preventive Medicine (Auger), School of Public Health

2021 EvidenceUpdates

31. Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial

Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial - PubMed This site needs JavaScript to work properly (...) . Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account info Close Account Logged in as: username Search: Search Save Email Send to Display options Display options Format Save citation to file Format: Create file Cancel Email citation Subject: 1 selected item: 33676589 - PubMed To: Format: MeSH and other data Send email Cancel Add to Collections Create a new

2021 EvidenceUpdates

32. Effect of Layperson-Delivered, Empathy-Focused Program of Telephone Calls on Loneliness, Depression, and Anxiety Among Adults During the COVID-19 Pandemic: A Randomized Clinical Trial Full Text available with Trip Pro

Effect of Layperson-Delivered, Empathy-Focused Program of Telephone Calls on Loneliness, Depression, and Anxiety Among Adults During the COVID-19 Pandemic: A Randomized Clinical Trial Effect of Layperson-Delivered, Empathy-Focused Program of Telephone Calls on Loneliness, Depression, and Anxiety Among Adults During the COVID-19 Pandemic: A Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard (...) , Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account info Close Account Logged in as: username Search: Search Save Email Send to Display options Display options Format Save citation to file Format: Create file Cancel Email citation Subject: 1 selected item: 33620417 - PubMed To: Format: MeSH and other data Send email Cancel Add to Collections Create a new collection Add to an existing collection Name your collection: Name must be less than

2021 EvidenceUpdates

33. Early prognostication of COVID-19 to guide hospitalisation versus outpatient monitoring using a point-of-test risk prediction score Full Text available with Trip Pro

Early prognostication of COVID-19 to guide hospitalisation versus outpatient monitoring using a point-of-test risk prediction score Early prognostication of COVID-19 to guide hospitalisation versus outpatient monitoring using a point-of-test risk prediction score - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information (...) of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Thorax Actions . 2021 Mar 10;thoraxjnl-2020-216425. doi: 10.1136/thoraxjnl-2020-216425. Online ahead of print. Early prognostication of COVID-19 to guide hospitalisation versus outpatient monitoring using a point-of-test risk prediction score # , # , # , , , , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Interstitial Lung Disease Unit

2021 EvidenceUpdates

34. A Characteristic Chest Radiographic Pattern in the Setting of the COVID-19 Pandemic Full Text available with Trip Pro

A Characteristic Chest Radiographic Pattern in the Setting of the COVID-19 Pandemic A Characteristic Chest Radiographic Pattern in the Setting of the COVID-19 Pandemic - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account info Close Account Logged in as: username Search: Search Save Email Send to Display (...) Format Share Permalink Copy Page navigation Radiol Cardiothorac Imaging Actions . 2020 Sep 3;2(5):e200280. doi: 10.1148/ryct.2020200280. eCollection 2020 Oct. A Characteristic Chest Radiographic Pattern in the Setting of the COVID-19 Pandemic , , , Affiliations Expand Affiliation 1 Department of Diagnostic Radiology, Louisiana State University Health Sciences Center, 1542 Tulane Ave, Room 343, New Orleans, LA 70112 (D.L.S., J.P.G., B.S.); and Department of Physics & Astronomy, Louisiana State

2021 EvidenceUpdates

35. Nomogram for prediction of fatal outcome in patients with severe COVID-19: a multicenter study Full Text available with Trip Pro

. References Gong J, Ou J, Qiu X, Jie Y, Chen Y, Yuan L, Cao J, Tan M, Xu W, Zheng F, Shi Y, Hu B, et al. A tool to early predict severe corona virus disease 2019 (COVID-19): a multicenter study using the risk nomogram in Wuhan and Guangdong, China. Clin Infect Dis. 2020;71(15):833–840. doi: 10.1093/cid/ciaa443. - - - Guan WJ, Ni ZY, Hu Y, Liang WH, Qu CQ, He JX, et al. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv. 2020:02.06.20020974. Wang D, Hu B, Hu C, Zhu F, Liu X (...) , Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi: 10.1001/jama.2020.1585. - - - Menzella F, Fontana M, Salvarani C, Massari M, Ruggiero P, Chiara Scelfo C, et al. Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation. Crit Care. 2020;24(1):589. doi: 10.1186/s13054-020-03306-6

2021 EvidenceUpdates

36. Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project) Full Text available with Trip Pro

hospitalized with severe Covid-19. N Engl J Med. 2020;382:1787–99. 10.1056/NEJMoa2001282 - - - Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. 10.1016/S0140-6736(20)30183-5 - - - Chan JF, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al.. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet (...) Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project) Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project) - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features

2021 EvidenceUpdates

37. Current evidence for COVID-19 therapies: a systematic literature review Full Text available with Trip Pro

Current evidence for COVID-19 therapies: a systematic literature review Current evidence for COVID-19 therapies: a systematic literature review - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account info Close Account Logged in as: username Search: Search Save Email Send to Display options Display options (...) Page navigation Eur Respir Rev Actions . 2021 Mar 17;30(159):200384. doi: 10.1183/16000617.0384-2020. Print 2021 Mar 31. Current evidence for COVID-19 therapies: a systematic literature review , , , , , Affiliations Expand Affiliations 1 Dept of Pulmonary and Infectious Diseases, Hannover University School of Medicine, Germany. 2 Prime Global, Oxford, UK. 3 Prime Global, Knutsford, UK. 4 AstraZeneca, Cambridge, UK. PMID: 33731328 DOI: Free article Item in Clipboard Current evidence for COVID-19

2021 EvidenceUpdates

38. Guidance for contacts of people with confirmed coronavirus (COVID-19) infection who do not live with the person

Guidance for contacts of people with confirmed coronavirus (COVID-19) infection who do not live with the person Guidance for contacts of people with confirmed coronavirus (COVID-19) infection who do not live with the person - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance (...) and support Guidance Guidance for contacts of people with confirmed coronavirus (COVID-19) infection who do not live with the person Guidance for contacts of a person with a positive test result for coronavirus (COVID-19) who do not live with that person. Published 28 May 2020 Last updated 17 June 2020 — From: Documents HTML Details This guidance is for people who have been notified by NHS Test and Trace that they are a contact of a person who has had a positive test result for coronavirus (COVID-19

2021 Public Health England

39. COVID-19: advice for smokers and vapers

COVID-19: advice for smokers and vapers COVID-19: advice for smokers and vapers - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Guidance COVID-19: advice for smokers and vapers Advice for people who smoke or vape during the coronavirus (COVID-19) outbreak. Published (...) 29 May 2020 From: Documents HTML Details People who smoke generally have an increased risk of contracting respiratory infection and of more severe symptoms once infected. Coronavirus (COVID-19) symptoms may therefore be more severe for smokers. This guidance advises how to reduce the risk of contracting COVID-19 for those who smoke or vape, and how to access support to stop smoking and remain smokefree. Published 29 May 2020 Related content Explore the topic Is this page useful? Thank you

2021 Public Health England

40. COVID-19: paediatric surveillance

COVID-19: paediatric surveillance COVID-19: paediatric surveillance - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Coronavirus guidance is being updated. Read Stay alert. Control the virus. Save lives. Guidance COVID-19: paediatric surveillance Description and contact details of PHE (...) paediatric surveillance programmes for COVID-19. Published 27 April 2020 From: Paediatric surveillance for . If you would like more information about the surveillance, please contact Dr Shamez Ladhani at . 2. Clinical follow up of laboratory-confirmed cases in neonates up to 28 days of age . Paediatricians across the UK and Ireland will receive weekly emails from the . For more information about the . At the end of the surveillance, cases will be linked to a similar surveillance of . For more information

2021 Public Health England